HIGHLIGHTS
SUMMARY
The safety of a drug is as important as its efficacy. Pharmaceutical companies consistently invest numerous material, financial, and human resources into clinical trials to discover the possible safety risks of drugs. Several public resources contain information relevant to drug toxicity (e_g, websites from regulatory agencies, World Health Organization`s consolidated list for withdrawn drugs, and scientific literature). For drugs corresponding to two or more categories (e_g, rabeprazole corresponds to both categories "B" and "C" from different packagers), the category indicating the higher risk was selected. For instance, the illustrated application case suggested that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.